Latest California Healthline Stories
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
Laws in California and most other states allow pharmacists to provide naloxone to patients or their friends without a doctor’s prescription. But many don’t do so, citing lack of demand and awareness among patients, their own fears of insufficient compensation and the challenges of treating opioid users.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
Behavioral care was at least four times more likely to be out-of-network than medical or surgical care, an analysis by Milliman shows.
Based on research conducted at the University of Michigan’s medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
Even though consumers don’t expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
What will the mega-merger mean for consumers and the health care industry? Senior correspondent Chad Terhune offers insight.
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in “imminent danger.”